These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression. Liu Y, Qing L, Meng C, Shi J, Yang Y, Wang Z, Han G, Wang Y, Ding J, Meng LH, Wang Q. J Med Chem; 2017 Apr 13; 60(7):2764-2779. PubMed ID: 28333459 [Abstract] [Full Text] [Related]
6. In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cells. Liu J, He Y, Zhang D, Cai Y, Zhang C, Zhang P, Zhu H, Xu N, Liang S. Mol Med Rep; 2017 Sep 13; 16(3):2595-2603. PubMed ID: 28677760 [Abstract] [Full Text] [Related]
7. Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents. Omran Z, Guise CP, Chen L, Rauch C, Abdalla AN, Abdullah O, Sindi IA, Fischer PM, Smaill JB, Patterson AV, Liu Y, Wang Q. Molecules; 2021 Jun 01; 26(11):. PubMed ID: 34206005 [Abstract] [Full Text] [Related]
10. Asymmetric synthesis of phenanthroindolizidine alkaloids with hydroxyl group at the C14 position and evaluation of their antitumor activities. Ikeda T, Yaegashi T, Matsuzaki T, Hashimoto S, Sawada S. Bioorg Med Chem Lett; 2011 Jan 01; 21(1):342-5. PubMed ID: 21126872 [Abstract] [Full Text] [Related]
12. Anticancer effect and neurotoxicity of S-(+)-deoxytylophorinidine, a new phenanthroindolizidine alkaloid that interacts with nucleic acids. Liu ZJ, Lv HN, Li HY, Zhang Y, Zhang HJ, Su FQ, Si YK, Yu SS, Chen XG. J Asian Nat Prod Res; 2011 May 01; 13(5):400-8. PubMed ID: 21534037 [Abstract] [Full Text] [Related]
13. First synthesis and pharmacological evaluation of benzoindolizidine and benzoquinolizidine analogues of alpha- and beta-peltatin. Couture A, Deniau E, Grandclaudon P, Lebrun S, Léonce S, Renard P, Pfeiffer B. Bioorg Med Chem; 2000 Aug 01; 8(8):2113-25. PubMed ID: 11003157 [Abstract] [Full Text] [Related]
14. Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents. Gao W, Bussom S, Grill SP, Gullen EA, Hu YC, Huang X, Zhong S, Kaczmarek C, Gutierrez J, Francis S, Baker DC, Yu S, Cheng YC. Bioorg Med Chem Lett; 2007 Aug 01; 17(15):4338-42. PubMed ID: 17531481 [Abstract] [Full Text] [Related]
15. Design, synthesis, antiviral activity, and structure-activity relationships (SARs) of two types of structurally novel phenanthroindo/quinolizidine analogues. Su B, Chen F, Wang L, Wang Q. J Agric Food Chem; 2014 Feb 12; 62(6):1233-9. PubMed ID: 24467600 [Abstract] [Full Text] [Related]
16. Isolation and biological activities of phenanthroindolizidine and septicine alkaloids from the Formosan Tylophora ovata. Lee YZ, Huang CW, Yang CW, Hsu HY, Kang IJ, Chao YS, Chen IS, Chang HY, Lee SJ. Planta Med; 2011 Nov 12; 77(17):1932-8. PubMed ID: 21728149 [Abstract] [Full Text] [Related]
17. Indolizidine and quinolizidine alkaloids. Michael JP. Nat Prod Rep; 2008 Feb 12; 25(1):139-65. PubMed ID: 18250900 [Abstract] [Full Text] [Related]
20. Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus. Yang CW, Lee YZ, Kang IJ, Barnard DL, Jan JT, Lin D, Huang CW, Yeh TK, Chao YS, Lee SJ. Antiviral Res; 2010 Nov 12; 88(2):160-8. PubMed ID: 20727913 [Abstract] [Full Text] [Related] Page: [Next] [New Search]